CHIERON ACTIVE INGREDIENTS PRIVATE LTD

Overview

CHIERON ACTIVE INGREDIENTS PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 22 active FDA Type II Drug Master Files, covering 1-CHLORO-6,6-DIMETHYLHEPT-2-EN-4-YNE; DAPAGLIFLOZIN PROPANEDIOL; ESCITALOPRAM OXALATE USP; FLUCONAZOLE USP; IRBESARTAN USP; LACOSAMIDE.

API / Drug Master Files

CHIERON ACTIVE INGREDIENTS PRIVATE LTD holds 22 active (22 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• DAPAGLIFLOZIN PROPANEDIOLActive2025-11-27
• RITALINIC ACIDActive2025-10-23
• RIVAROXABAN USPActive2025-07-01
• SITAGLIPTIN PHOSPHATE MONOHYDRATE USPActive2025-06-12
• ESCITALOPRAM OXALATE USPActive2025-05-06
• N-METHYL-1-NAPHTHYLMETHYLAMINE HYDROCHLORIDEActive2025-04-24
• 1-CHLORO-6,6-DIMETHYLHEPT-2-EN-4-YNEActive2025-04-23
• IRBESARTAN USPActive2023-10-04
• S-(-)-4-[4-(DIMETHYLAMINO)-1-(4- FLUOROPHENYL)-1-HYDROXY]BUTYL-3-HYDROXY-METHYL BENZONITRILE D(+) DI-P-TOLUOYL TARTRATE SALTActive2023-09-28
• FLUCONAZOLE USPActive2023-09-07
• TERBINAFINE HYDROCHLORIDE USPActive2023-02-24
• WARFARIN SODIUM CLATHRATEActive2021-10-14
• TETRACAINE HYDROCHLORIDEActive2021-06-22
• VILDAGLIPTINActive2021-05-21
• RISPERIDONEActive2021-03-26

Showing 15 of 22 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CHIERON ACTIVE INGREDIENTS PRIVATE LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.